Format

Send to

Choose Destination
J Thorac Oncol. 2012 Dec;7(12):e36-e38. doi: 10.1097/JTO.0b013e318274694e.

A dramatic response to crizotinib in a non-small-cell lung cancer patient with IHC-positive and FISH-negative ALK.

Author information

1
Department of Medicine, Division of Hematology-Oncology, Sungkyunkwan University School of Medicine, Seoul, Korea. Electronic address: tntntn3@gmail.com.
2
Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
3
Molecular Pathology Center, Seoul National University Cancer Hospital, Seoul, Korea.
4
Department of Medicine and Pathology, University of Colorado, Anschutz Medical Campus, Aurora, Colorado.
5
Department of Medicine, Division of Hematology-Oncology, Sungkyunkwan University School of Medicine, Seoul, Korea.
PMID:
23154564
DOI:
10.1097/JTO.0b013e318274694e
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center